TAKP34:BVMF
Takeda Pharmaceutical Co Ltd BDR
90,54 BRL
0,00%
(0,00) 1 d.
6. 10., 15:21:39 GMT-3 · BRL
search
Všetky symboly
| Symbol | Cena | Zmena | % zmeny |
|---|
insights_autoGenerujú sa najdôležitejšie štatistiky pre TAKP34…
Trh. kap.
59,62 mld.
Priem. obj.
36,00
Objem
0,00
Max. za 52 týž.
102,65 BRL
Min. za 52 týž.
70,80 BRL
Akcie v obehu
1,60 mld.
Počet zamestnancov
47 tis.
Trh. kap.
59,62 mld.
Priem. obj.
36,00
Objem
0,00
Max. za 52 týž.
102,65 BRL
Min. za 52 týž.
70,80 BRL
Akcie v obehu
1,60 mld.
Počet zamestnancov
47 tis.
Spravodajstvo
Z internetových zdrojov a od spravodajských partnerov
AD HOC NEWS
·
pred 13 hodinami
Takeda Pharmaceutical stock is unchanged at EUR 16.55 this week
AD HOC NEWS
·
pred 1 mesiacom
Takeda Pharmaceutical stock after-hours at EUR 16.55: unchanged
Profil
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda. In 2026, Julie Kim was noted in a news item as "CEO-elect". Wikipedia
Informácie o subjekte Takeda Pharmaceutical Co Ltd BDR
Generálny riaditeľChristophe Weber | Christophe Weber
Zamestnanci47 tis.
Dátum založenia12. 6. 1781
Hlavné sídlo-
Odvetvie-
Webtakeda.com